Pilot Study Among Type 2 Diabetes Patients Investigating the Effects of Computerized Cognitive and Physical Activity Programs Combined or Single (DIASCOP) (DIASCOP)

May 31, 2021 updated by: University Hospital, Clermont-Ferrand

Pilot Study Among Type 2 Diabetes Patients Investigating Effects of Computerized Cognitive and Physical Activity Programs Combined or Single.

The purpose of this study is to assess the cognitive benefits of combined physical activity and cognitive training on cognitive health compare to physical activity or cognitive training programs singly administrated among type 2 diabetes. Two group in cross over will take part in either physical activity only (for the first one) or cognitive training only (for the second one) for one month then the other way around during the second month. A fallow up will be administrated 3 months later.

Study Overview

Detailed Description

The growing Type 2 diabetes prevalence is associated with health, economic and social consequences. As such, type 2 diabetes is recognized as major health issue. Health care should go on after being discharged from the hospital in order to promote cognitive autonomy. Physical activity and cognitive training are two interventions often recommended individually to benefit cognition among type 2 diabetes patients. Yet, a program combining physical activity and cognitive training might be more effective to favor cognitive health.

In this study, diabetes patient between 50 and 75 years old will be allocated randomly in 3 intervention groups in order to have a homogeneous distribution of the education level, sex and age across the 3 samples. The first group will take part in a physical activity program the first month and in a cognitive training one the second. The second group will be cross-over meaning taking part in a cognitive training program the first month and engaging in the physical activity one the second month. The last group will engage in a program based on resonance frequency breathing the first month (as a control condition), then in a combined physical activity and cognitive training program. Between the 2 interventions, there will be a 15 days break (limiting the transfer of the effect of one intervention onto another). At the beginning of the study, a screening will allow to identify possible exclusion criteria (health factors that could influence the main outcomes). At the beginning (baseline) of the first intervention and after each month, neuropsychological tests assessing cognitive and psychological health as well as well-being. Physiological parameters such as heart rate variability, cortisol and DHEA levels, muscle and lean mass, blood circulation (assessed by Laser speckle contrast imaging). A whole session (psychological and physiological testing) should take 1 h 30. Besides, participants will complete online questionnaires. They have one week after the testing to complete those surveys. If they are late an email will be sent before a phone call in the case the delay goes on.

The main outcome is the increase of the cognitive variables after the intervention. It is expected that the physical activity and cognitive training combined program will benefit cognitive functioning more than either of those programs administrated individually. To investigate to long-term effects of the intervention, a fallow up 3 months later will be conduct

Study Type

Interventional

Enrollment (Anticipated)

81

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-Ferrand, France, 63000
        • CHU de Clermont-Ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Male or female aged between 50 and 70 years old, suffering from type 2 diabetes.

Normal or corrected sight and audition. Being able to engage in physical activity. Being able to give enlightened consent. Being affiliate to social welfare

Exclusion Criteria:

Being unable to meet the study conditions or to answer in French to surveys. Any condition considered, by the investigator, as incompatible with the participation in the study.

Major incapacities. Refusal of participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group 1: physical activity then cognitive training
Using an online-computerized application, physical activities will be prescribed for one month. After a 15 days break, cognitive training activities will be prescribed the same way. A feedback by the patient will be asked fallowing each activity to control the observance.
The intervention is administrated through a computerized application as prescribed exercises (cognitive or physical). The specific measures that will be used to determine the effect of the intervention are psychological variables (mood, anxiety, well-being, cognitive variables…) and physical ones (Heart rate variability, stress biomarkers, fat and muscle mass, blood circulation…).
The intervention is administrated through a computerized application as prescribed exercises (cognitive or physical). The specific measures that will be used to determine the effect of the intervention are psychological variables (mood, anxiety, well-being, cognitive variables…) and physical ones (Heart rate variability, stress biomarkers, fat and muscle mass, blood circulation…).
Experimental: Group 2: Cognitive training then physical activity
Contrary to the first group, the second one starts with cognitive training intervention then engages in physical activity in same way as the first group. A feedback by the patient will also be asked fallowing each activity to control the observance
The intervention is administrated through a computerized application as prescribed exercises (cognitive or physical). The specific measures that will be used to determine the effect of the intervention are psychological variables (mood, anxiety, well-being, cognitive variables…) and physical ones (Heart rate variability, stress biomarkers, fat and muscle mass, blood circulation…).
The intervention is administrated through a computerized application as prescribed exercises (cognitive or physical). The specific measures that will be used to determine the effect of the intervention are psychological variables (mood, anxiety, well-being, cognitive variables…) and physical ones (Heart rate variability, stress biomarkers, fat and muscle mass, blood circulation…).
Experimental: Group 3 : resonance frequency breathing then combined physical activity and cognitive training
The third group takes part in a 1 month breathing exercise program. After a 15 days break (as the groups 1 and 2), a combined physical activity and cognitive training program is administrated for 1 month. As the others arms, a feedback by the patient will be asked fallowing each activity to control the observance
The intervention is administrated through a computerized application as prescribed exercises (cognitive or physical). The specific measures that will be used to determine the effect of the intervention are psychological variables (mood, anxiety, well-being, cognitive variables…) and physical ones (Heart rate variability, stress biomarkers, fat and muscle mass, blood circulation…).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Episodic memory performances
Time Frame: Month 1 (Between 1 day and a week before and after the first intervention)
Scores are obtained from delayed memory recall tests from the logical memory subtest of the Wechsler memory scale. It consists of two short narrative stories with an immediate recall phase after each story and a delayed recall phase after 10 minutes. During the delayed recall, each correct detail was awarded with one score point. On a scale of 0 to 50, a higher score means a better detailed recall.
Month 1 (Between 1 day and a week before and after the first intervention)
Episodic memory performances
Time Frame: Month 2 (a week after the second intervention)
Scores are obtained from delayed memory recall tests from the logical memory subtest of the Wechsler memory scale. It consists of two short narrative stories with an immediate recall phase after each story and a delayed recall phase after 10 minutes. During the delayed recall, each correct detail was awarded with one score point. On a scale of 0 to 50, a higher score means a better detailed recall.
Month 2 (a week after the second intervention)
Episodic memory performances
Time Frame: Month 3
Scores are obtained from delayed memory recall tests from the logical memory subtest of the Wechsler memory scale. It consists of two short narrative stories with an immediate recall phase after each story and a delayed recall phase after 10 minutes. During the delayed recall, each correct detail was awarded with one score point. On a scale of 0 to 50, a higher score means a better detailed recall.
Month 3

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rate variability
Time Frame: Month 1 (Between 1 day and a week before and after the first intervention)
Time interval between two heart beats assessed by a monitoring watch (Empatica E4) and belt (Zephyr Bioharness 3)
Month 1 (Between 1 day and a week before and after the first intervention)
Heart rate variability
Time Frame: Month 2 (a week after the second intervention)
Time interval between two heart beats assessed by a monitoring watch (Empatica E4) and belt (Zephyr Bioharness 3)
Month 2 (a week after the second intervention)
Heart rate variability
Time Frame: Month 3
Time interval between two heart beats assessed by a monitoring watch (Empatica E4) and belt (Zephyr Bioharness 3)
Month 3
Blood circulation
Time Frame: Month 1 (Between 1 day and a week before and after the first intervention)
Assessed by laser speckle contrast imaging (LSCI).
Month 1 (Between 1 day and a week before and after the first intervention)
Blood circulation
Time Frame: Month 2 (a week after the second intervention)
Assessed by laser speckle contrast imaging (LSCI).
Month 2 (a week after the second intervention)
Blood circulation
Time Frame: Month 3
Assessed by laser speckle contrast imaging (LSCI).
Month 3
Biomarkers of stress
Time Frame: Month 1 (Between 1 day and a week before and after the first intervention)
A salivary sample to test cortisol level and DHEA.
Month 1 (Between 1 day and a week before and after the first intervention)
Biomarkers of stress
Time Frame: Month 2 (a week after the second intervention)
A salivary sample to test cortisol level and DHEA.
Month 2 (a week after the second intervention)
Biomarkers of stress
Time Frame: Month 3
A salivary sample to test cortisol level and DHEA.
Month 3
Body Mass index
Time Frame: Month 1 (Between 1 day and a week before and after the first intervention)
The ratio between weight and height will be computed to report BMI in kg/m2.
Month 1 (Between 1 day and a week before and after the first intervention)
Body Mass index
Time Frame: Month 2 (a week after the second intervention)
The ratio between weight and height will be computed to report BMI in kg/m2.
Month 2 (a week after the second intervention)
Body Mass index
Time Frame: Month 3
The ratio between weight and height will be computed to report BMI in kg/m2.
Month 3
Life satisfaction scale
Time Frame: Month 1 (Between 1 day and a week before and after the first intervention)
This scale assesses the feeling of satisfaction of one's life. This scale has 5 items. The minimum score is 5 and the maximum score is 35. A higher score means a higher life satisfaction level.
Month 1 (Between 1 day and a week before and after the first intervention)
Life satisfaction scale
Time Frame: Month 2 (a week after the second intervention)
This scale assesses the feeling of satisfaction of one's life. This scale has 5 items. The minimum score is 5 and the maximum score is 35. A higher score means a higher life satisfaction level.
Month 2 (a week after the second intervention)
Life satisfaction scale
Time Frame: Month 3
This scale assesses the feeling of satisfaction of one's life. This scale has 5 items. The minimum score is 5 and the maximum score is 35. A higher score means a higher life satisfaction level.
Month 3
Psychological Outcome Profiles
Time Frame: Month 1 (Between 1 day and a week before and after the first intervention)
This survey assesses the patient's satisfaction level before and after the intervention. Five items with a 6-points Likert scale (0 to 5) allow to obtain a score between 0 and 25. A higher score means a better satisfaction level
Month 1 (Between 1 day and a week before and after the first intervention)
Psychological Outcome Profiles
Time Frame: Month 2 (a week after the second intervention)
This survey assesses the patient's satisfaction level before and after the intervention. Five items with a 6-points Likert scale (0 to 5) allow to obtain a score between 0 and 25. A higher score means a better satisfaction level
Month 2 (a week after the second intervention)
Psychological Outcome Profiles
Time Frame: Month 3
This survey assesses the patient's satisfaction level before and after the intervention. Five items with a 6-points Likert scale (0 to 5) allow to obtain a score between 0 and 25. A higher score means a better satisfaction level
Month 3
Interoception awareness questionnaire
Time Frame: Month 1 (Between 1 day and a week before and after the first intervention)
To assess the awareness of both neutral and negative bodily signals, this scale has 19 items with a 5-points Likert scale (1 to 5). The minimum total score is 9 while the maximum is 95. A higher score means a higher perception of bodily signals.
Month 1 (Between 1 day and a week before and after the first intervention)
Interoception awareness questionnaire
Time Frame: Month 2 (a week after the second intervention)
To assess the awareness of both neutral and negative bodily signals, this scale has 19 items with a 5-points Likert scale (1 to 5). The minimum total score is 9 while the maximum is 95. A higher score means a higher perception of bodily signals.
Month 2 (a week after the second intervention)
Interoception awareness questionnaire
Time Frame: Month 3
To assess the awareness of both neutral and negative bodily signals, this scale has 19 items with a 5-points Likert scale (1 to 5). The minimum total score is 9 while the maximum is 95. A higher score means a higher perception of bodily signals.
Month 3
BORB Birmingham Object Recognition Battery
Time Frame: Month 1 (Between 1 day and a week before and after the first intervention)
To assess visuospatial processing by asking the participants if two stimuli are orientated the same way.
Month 1 (Between 1 day and a week before and after the first intervention)
BORB Birmingham Object Recognition Battery
Time Frame: Month 2 (a week after the second intervention)
To assess visuospatial processing by asking the participants if two stimuli are orientated the same way.
Month 2 (a week after the second intervention)
BORB Birmingham Object Recognition Battery
Time Frame: Month 3
To assess visuospatial processing by asking the participants if two stimuli are orientated the same way.
Month 3
Executive functions
Time Frame: Month 1 (Between 1 day and a week before and after the first intervention)
A battery of 5 tests assessing cognitive inhibition (Stroop and Go/No-Go), cognitive flexibility (Trail Making Test), working memory (Nback) and lexical access (verbal fluency) to reflect executive functioning.
Month 1 (Between 1 day and a week before and after the first intervention)
Executive functions
Time Frame: Month 2 (a week after the second intervention)
A battery of 5 tests assessing cognitive inhibition (Stroop and Go/No-Go), cognitive flexibility (Trail Making Test), working memory (Nback) and lexical access (verbal fluency) to reflect executive functioning.
Month 2 (a week after the second intervention)
Executive functions
Time Frame: Month 3
A battery of 5 tests assessing cognitive inhibition (Stroop and Go/No-Go), cognitive flexibility (Trail Making Test), working memory (Nback) and lexical access (verbal fluency) to reflect executive functioning.
Month 3
The emotion regulation questionnaire
Time Frame: Month 1 (Between 1 day and a week before and after the first intervention)
A questionnaire to measure emotion regulation strategies one favors such as emotion suppression or cognitive reappraisal. This questionnaire has 10 items with a 5-points Likert scale (1 to 5). The score ranges from 5 to 50. A higher score means better emotion regulation strategies.
Month 1 (Between 1 day and a week before and after the first intervention)
The emotion regulation questionnaire
Time Frame: Month 2 (a week after the second intervention)
A questionnaire to measure emotion regulation strategies one favors such as A questionnaire to measure emotion regulation strategies one favors such as emotion suppression or cognitive reappraisal. This questionnaire has 10 items with a 5-points Likert scale (1 to 5). The score ranges from 5 to 50. A higher score means better emotion regulation strategies.
Month 2 (a week after the second intervention)
The emotion regulation questionnaire
Time Frame: Month 3
A questionnaire to measure emotion regulation strategies one favors such as emotion suppression or cognitive reappraisal. This questionnaire has 10 items with a 5-points Likert scale (1 to 5). The score ranges from 5 to 50. A higher score means better emotion regulation strategies.
Month 3
Beck Depression Scale
Time Frame: Month 1 (Between 1 day and a week before and after the first intervention)
To estimate the level of depression among adults, this scale has 13 items with a 4-points Likert scale (0 to 3). The score ranges from 0 to 39, a higher score means a higher level of depression.
Month 1 (Between 1 day and a week before and after the first intervention)
Beck Depression Scale
Time Frame: Month 2 (a week after the second intervention)
To estimate the level of depression among adults, this scale has 13 items with a 4-points Likert scale (0 to 3). The score ranges from 0 to 39, a higher score means a higher level of depression.
Month 2 (a week after the second intervention)
Beck Depression Scale
Time Frame: Month 3
To estimate the level of depression among adults, this scale has 13 items with a 4-points Likert scale (0 to 3). The score ranges from 0 to 39, a higher score means a higher level of depression.
Month 3
Fat/lean mass ratio
Time Frame: Month 1 (Between 1 day and a week before and after the first intervention)
The bio-electrical impedance analysis measurements will include total body fat mass (FM in kg), and total body lean mass (LM in kg). Then the fat/lean mass (F/L) ratio will be calculated.
Month 1 (Between 1 day and a week before and after the first intervention)
Fat/lean mass ratio
Time Frame: Month 2 (a week after the second intervention)
The bio-electrical impedance analysis measurements will include total body fat mass (FM in kg), and total body lean mass (LM in kg). Then the fat/lean mass (F/L) ratio will be calculated.
Month 2 (a week after the second intervention)
Fat/lean mass ratio
Time Frame: Month 3
The bio-electrical impedance analysis measurements will include total body fat mass (FM in kg), and total body lean mass (LM in kg). Then the fat/lean mass (F/L) ratio will be calculated.
Month 3
Client satisfaction questionnaire
Time Frame: Month 1 (Between 1 day and a week before and after the first intervention)
This survey assesses the patient's satisfaction level of the intervention. Eight items with a 4-points Likert scale (1 to 4) allow to obtain a score between 8 and 32. A higher score means a better satisfaction level.
Month 1 (Between 1 day and a week before and after the first intervention)
Client satisfaction questionnaire
Time Frame: Month 2 (a week after the second intervention)
This survey assesses the patient's satisfaction level of the intervention. Eight items with a 4-points Likert scale (1 to 4) allow to obtain a score between 8 and 32. A higher score means a better satisfaction level.
Month 2 (a week after the second intervention)
Client satisfaction questionnaire
Time Frame: Month 3
This survey assesses the patient's satisfaction level of the intervention. Eight items with a 4-points Likert scale (1 to 4) allow to obtain a score between 8 and 32. A higher score means a better satisfaction level.
Month 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

June 1, 2021

Primary Completion (Anticipated)

September 1, 2022

Study Completion (Anticipated)

June 1, 2023

Study Registration Dates

First Submitted

May 21, 2021

First Submitted That Met QC Criteria

May 31, 2021

First Posted (Actual)

June 7, 2021

Study Record Updates

Last Update Posted (Actual)

June 7, 2021

Last Update Submitted That Met QC Criteria

May 31, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • RBHP 2020 DUTHEIL
  • 2020-A03228-31 (Other Identifier: ANSM)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus, Type 2

Clinical Trials on Physical activity

3
Subscribe